Analyst Insight: The pharmaceutical industry is finally sharpening its focus on profitability and efficiency. 2014 saw continued mergers and acquisitions, but more importantly, the acceleration of business focus on core sectors. Now that the impacts of the Affordable Care Act are better understood, the ability to streamline operations into sectors is driving spin-offs, sell-offs and renewed operational pressures. Two key drivers this year involving supply chains will be inventory reduction and control and lean cost reduction. – Brian Hudock, Partner, Tompkins International
Analyst Insight: The pressures faced by the pharmaceutical industry are well known. These include the increasing cost of healthcare, the aging of the population in the developed world, market entry hurdles in many emerging markets, excess manufacturing capacity, reimbursement decisions based on comparative effectiveness research, and the continued adoption of generics and bio-similars. Another well-known about the industry: change occurs at a glacial pace. What role does the supply chain have in helping the industry transition to a solution-oriented approach to healthcare? – Barry Blake, Vice President, Research, SCM World
From new regulations to the growth in large-molecule temperature-sensitive products to the frequency of disruptions, healthcare companies are operating in a risk-inherent environment that is at the same time rich with new opportunities. There are favorable demographics on the horizon as populations age, become more affluent and expand in a diverse set of geographies. Meanwhile, the supply chain must stretch to accommodate new distribution channels, product specialization and innovation.